N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide
C19H21ClF3N5O2 — CID 118023540
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide
N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide (PubChem CID 118023540) has the molecular formula C19H21ClF3N5O2 and a molecular weight of 443.86 g/mol. Its IUPAC name is N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide.
Molecular Properties
| Compound Name | N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide |
|---|---|
| PubChem CID | 118023540 |
| Molecular Formula | C19H21ClF3N5O2 |
| Molecular Weight | 443.86 g/mol |
| Exact Mass | 443.13 |
| IUPAC Name | N-(3-chloro-1-pyridin-3-ylpyrazol-4-yl)-N-ethyl-2-[2-oxo-3-(3,3,3-trifluoropropyl)pyrrolidin-1-yl]acetamide |
| SMILES | CCN(C(=O)CN1CCC(CCC(F)(F)F)C1=O)c1cn(-c2cccnc2)nc1Cl |
| InChI | InChI=1S/C19H21ClF3N5O2/c1-2-27(15-11-28(25-17(15)20)14-4-3-8-24-10-14)16(29)12-26-9-6-13(18(26)30)5-7-19(21,22)23/h3-4,8,10-11,13H,2,5-7,9,12H2,1H3 |
| InChIKey | NKUBLZKMQBLOSP-UHFFFAOYSA-N |
| XLogP | 3.46 |
| TPSA | 71.33 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.86 |
| LogP ≤ 5 | 3.46 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118023540 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.